RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.250
+0.100 (8.70%)
Dec 20, 2024, 4:00 PM EST - Market closed
RenovoRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 4.89 | 5.73 | 5.65 | 2.63 | 0.82 | 0.9 |
| Research & Development | 5.22 | 5.67 | 4.3 | 3.04 | 2.39 | 3 |
| Operating Expenses | 10.12 | 11.4 | 9.95 | 5.67 | 3.2 | 3.9 |
| Operating Income | -10.12 | -11.4 | -9.95 | -5.67 | -3.2 | -3.9 |
| Interest Expense | - | - | - | -0.83 | -0.59 | - |
| Interest & Investment Income | 0.31 | 0.11 | 0.06 | - | - | 0.06 |
| Other Non Operating Income (Expenses) | 0.64 | 1.06 | 0 | 0.12 | -0.01 | -0.01 |
| EBT Excluding Unusual Items | -9.16 | -10.23 | -9.89 | -6.39 | -3.8 | -3.84 |
| Other Unusual Items | - | - | - | 0.06 | - | - |
| Pretax Income | -9.16 | -10.23 | -9.89 | -6.32 | -3.8 | -3.84 |
| Net Income | -9.16 | -10.23 | -9.89 | -6.32 | -3.8 | -3.84 |
| Net Income to Common | -9.16 | -10.23 | -9.89 | -6.32 | -3.8 | -3.84 |
| Shares Outstanding (Basic) | 19 | 10 | 9 | 5 | 2 | 2 |
| Shares Outstanding (Diluted) | 19 | 10 | 9 | 5 | 2 | 2 |
| Shares Change (YoY) | 88.79% | 13.69% | 73.50% | 135.64% | 1.69% | - |
| EPS (Basic) | -0.49 | -0.99 | -1.09 | -1.21 | -1.72 | -1.76 |
| EPS (Diluted) | -0.49 | -0.99 | -1.09 | -1.21 | -1.72 | -1.76 |
| Free Cash Flow | -8.75 | -10.26 | -8.81 | -5.93 | -3.53 | -3.35 |
| Free Cash Flow Per Share | -0.47 | -1.00 | -0.97 | -1.14 | -1.59 | -1.54 |
| EBITDA | - | -11.39 | -9.94 | -5.66 | - | - |
| D&A For EBITDA | - | 0.01 | 0.01 | 0.01 | - | - |
| EBIT | -10.12 | -11.4 | -9.95 | -5.67 | -3.2 | -3.9 |
Source: S&P Capital IQ. Standard template.
Financial Sources.